TICRR has been identified as a robust prognostic biomarker in lung adenocarcinoma (LUAD) due to its involvement in critical biological processes such as immune activation, cell cycle regulation, RNA modification, and tumor energy metabolism. Here, TICRR is linked to neoplasm.